Category Specific RSS

ASX: MVP

Medical Developments eyes US commercialisation for Penthrox as it scales back in France

After scaling back investments in France and pulling the plug on its China trials, Aussie emergency medical solutions company Medical…

2 years ago

MVP discontinues clinical trials in China for Green Whistle, focuses on growth in the US

Perhaps China decided to make its own version of the drug or perhaps it proved that it could do so…

2 years ago

MVP eyes increased global distribution of Penthrox green whistle after raising $20m

Medical device company Medical Developments International (ASX:MVP) has successfully raised $20 million from institutional investors as part of their plans to…

3 years ago

New leadership and new focus, MVP reclaims distribution rights and margins

Australian pharmaceuticals company Medical Developments (ASX: MVP) is set to renew their international expansion targets with greater control having taken…

5 years ago

Medical Developments gains approval to commence Penthrox trials in China

Australian pharmaceuticals manufacturer Medical Developments International (ASX: MVP) has secured approval from the Chinese National Medical Product Administration (NMPA) to…

6 years ago

Australia’s green whistle pain relief winning over Europeans

Carried and administered by Australian paramedics for decades, the green whistle pain reliever has been on the Australian market for…

6 years ago